An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Clinical trial NCT06284226 · WITHDRAWN

Trial details

NCT number: NCT06284226
Sponsor: Beijing Kejing Biotechnology Co., Ltd.
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)

Start date: 2022-03-25
Primary completion: 2025-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.